Related Experiment Video
Updated: Nov 1, 2025
08:14
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.9K
Circulating miRNAs-A potential tool to identify severe asthma risk?
Mohammed A Kyyaly1,2,3, Tilman Sanchez-Elsner2,3, Peijun He4
1David Hide Asthma and Allergy Research Centre, Newport, Isle of Wight, UK.
Clinical and Translational Allergy
|June 23, 2021
Summary
Identifying severe asthma risk is crucial. New research shows specific microRNAs (miRNAs) in blood may serve as novel biomarkers for severe asthma, aiding early detection and risk assessment.
Area of Science:
- Biochemistry
- Genetics
- Pulmonology
Background:
- Severe asthma poses a significant health burden, yet reliable biomarkers for risk identification are lacking.
- Current diagnostic methods for asthma severity lack precision in identifying at-risk individuals.
Discussion:
- This study explored the potential of circulating microRNA (miRNA) panels to distinguish between mild and severe asthma patients.
- The research aimed to identify specific miRNAs that are differentially expressed in the serum of individuals with severe asthma.
Key Insights:
- Specific microRNAs, including miR-28-3p, miR-16-2-3p, and miR-210-3p, were identified as potentially novel serum biomarkers.
- These identified miRNAs have not been previously reported in the context of severe asthma serum expression.
Outlook:
- Circulating miRNA expression profiles show promise as non-invasive biomarkers for predicting severe asthma risk.
- Further research and validation are warranted to establish these miRNAs as clinical tools for severe asthma management.
